Do all roads lead to Oct4? The emerging concepts of induced pluripotency

Trends in Cell Biology

Volumn 24, Issue 5, 2014, Pages 275-284

  Radzisheuskaya, Aliaksandra ^a   Silva, José C R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cell differentiation; Cell state transitions; Embryonic stem cells; Induced pluripotent stem cells; Na ve pluripotency; Reprogramming

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN;

ANIMAL; CELL DIFFERENTIATION; GENETIC EPIGENESIS; HUMAN; NUCLEAR REPROGRAMMING; PHYSIOLOGY; PLURIPOTENT STEM CELL; PROTEIN TRANSPORT;

ANIMALS; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; EPIGENESIS, GENETIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN TRANSPORT;

EID: 84899490310     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2013.11.010     Document Type: Review

References (118)

1. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:7634-7638.
2. Smith A.G. Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 2001, 17:435-462.
3. Nichols J., Smith A. Naive and primed pluripotent states. Cell Stem Cell 2009, 4:487-492.
4. Nichols J., Smith A. Pluripotency in the embryo and in culture. Cold Spring Harb. Perspect. Biol. 2012, 4:a008128.
5. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
6. Nichols J., et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95:379-391.
7. Niwa H., et al. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
8. Avilion A.A., et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003, 17:126-140.
9. Masui S., et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 2007, 9:625-635.
10. Chambers I., et al. Nanog safeguards pluripotency and mediates germline development. Nature 2007, 450:1230-1234.
11. Martello G., et al. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 2012, 11:491-504.
12. Masui S., et al. Rex1/Zfp42 is dispensable for pluripotency in mouse ES cells. BMC Dev. Biol. 2008, 8:45.
13. Jiang J., et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 2008, 10:353-360.
14. Ye S., et al. Embryonic stem cell self-renewal pathways converge on the transcription factor Tfcp2l1. EMBO J. 2013, 32:2548-2560.
15. Martello G., et al. Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J. 2013, 32:2561-2574.
16. Chambers I., et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
17. Festuccia N., et al. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012, 11:477-490.
18. Hall J., et al. Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 2009, 5:597-609.
19. Niwa H., et al. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 2009, 460:118-122.
20. Kopp J.L., et al. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 2008, 26:903-911.
21. Kim J.B., et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009, 136:411-419.
22. Kim J.B., et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
23. Wu T., et al. Reprogramming of trophoblast stem cells into pluripotent stem cells by Oct4. Stem Cells 2011, 29:755-763.
24. Tsai S.Y., et al. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells 2011, 29:964-971.
25. Yuan X., et al. Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts. Stem Cells 2011, 29:549-553.
26. Li Y., et al. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res. 2011, 21:196-204.
27. Zhu S., et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 2010, 7:651-655.
28. Heng J.C., et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010, 6:167-174.
29. Gu P., et al. Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol. Cell. Biol. 2005, 25:3492-3505.
30. Barnea E., Bergman Y. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J. Biol. Chem. 2000, 275:6608-6619.
31. Gao Y., et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 2013, 12:453-469.
32. Costa Y., et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 2013, 495:370-374.
33. Buganim Y., et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 2012, 150:1209-1222.
34. Mansour A.A., et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature 2012, 488:409-413.
35. Zhang J., et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat. Cell Biol. 2006, 8:1114-1123.
36. Yang J., et al. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS ONE 2010, 5:e10766.
37. Gao X., et al. Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers. Stem Cell Reports 2013, 1:183-197.
38. Nakagawa M., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 2008, 26:101-106.
39. Niwa H., et al. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 2002, 22:1526-1536.
40. Esch D., et al. A unique Oct4 interface is crucial for reprogramming to pluripotency. Nat. Cell Biol. 2013, 15:295-301.
41. Frankenberg S., Renfree M.B. On the origin of POU5F1. BMC Biol. 2013, 11:56.
42. Frankenberg S., et al. The evolution of class V POU domain transcription factors in vertebrates and their characterisation in a marsupial. Dev. Biol. 2010, 337:162-170.
43. Tapia N., et al. Reprogramming to pluripotency is an ancient trait of vertebrate Oct4 and Pou2 proteins. Nat. Commun. 2012, 3:1279.
44. Niwa H., et al. Platypus Pou5f1 reveals the first steps in the evolution of trophectoderm differentiation and pluripotency in mammals. Evol. Dev. 2008, 10:671-682.
45. Morrison G.M., Brickman J.M. Conserved roles for Oct4 homologues in maintaining multipotency during early vertebrate development. Development 2006, 133:2011-2022.
46. Rossello R.A., et al. Mammalian genes induce partially reprogrammed pluripotent stem cells in non-mammalian vertebrate and invertebrate species. Elife 2013, 2:e00036.
47. Lu Y., et al. Avian-induced pluripotent stem cells derived using human reprogramming factors. Stem Cells Dev. 2012, 21:394-403.
48. Esteban M.A., et al. The mesenchymal-to-epithelial transition in somatic cell reprogramming. Curr. Opin. Genet. Dev. 2012, 22:423-428.
49. Ichida J.K., et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009, 5:491-503.
50. Maherali N., Hochedlinger K. Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr. Biol. 2009, 19:1718-1723.
51. Samavarchi-Tehrani P., et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.
52. Li R., et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010, 7:51-63.
53. Wang G., et al. Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:2858-2863.
54. Redmer T., et al. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep. 2011, 12:720-726.
55. Ho R., et al. Stage-specific regulation of reprogramming to induced pluripotent stem cells by Wnt signaling and T cell factor proteins. Cell Rep. 2013, 3:2113-2126.
56. Livigni A., et al. A conserved Oct4/POUV-dependent network links adhesion and migration to progenitor maintenance. Curr. Biol. 2013, 23:2233-2244.
57. Buganim Y., et al. Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 2013, 14:427-439.
58. Soufi A., et al. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 2012, 151:994-1004.
59. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
60. Papp B., Plath K. Epigenetics of reprogramming to induced pluripotency. Cell 2013, 152:1324-1343.
61. You J.S., et al. OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14497-14502.
62. Chen J., et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat. Genet. 2013, 45:34-42.
63. Loh Y.H., et al. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 2007, 21:2545-2557.
64. Shi Y., et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008, 2:525-528.
65. Feldman N., et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 2006, 8:188-194.
66. Athanasiadou R., et al. Targeting of de novo DNA methylation throughout the Oct-4 gene regulatory region in differentiating embryonic stem cells. PLoS ONE 2010, 5:e9937.
67. Loh K.M., Lim B. A precarious balance: pluripotency factors as lineage specifiers. Cell Stem Cell 2011, 8:363-369.
68. Shu J., et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 2013, 153:963-975.
69. Montserrat N., et al. Reprogramming of human fibroblasts to pluripotency with lineage specifiers. Cell Stem Cell 2013, 13:341-350.
70. Thomson M., et al. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell 2011, 145:875-889.
71. Wang Z., et al. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 2012, 10:440-454.
72. Takemoto T., et al. Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells. Nature 2011, 470:394-398.
73. Silva J., et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008, 6:e253.
74. Eminli S., et al. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008, 26:2467-2474.
75. Yamaguchi S., et al. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate. Stem Cell Res. 2011, 6:177-186.
76. Carey B.W., et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 2011, 9:588-598.
77. Papapetrou E.P., et al. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:12759-12764.
78. Tiemann U., et al. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells. Cytometry A 2011, 79:426-435.
79. Nagamatsu G., et al. Optimal ratio of transcription factors for somatic cell reprogramming. J. Biol. Chem. 2012, 287:36273-36282.
80. Radzisheuskaya A., et al. A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Nat. Cell Biol. 2013, 15:579-590.
81. Karwacki-Neisius V., et al. Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog. Cell Stem Cell 2013, 12:531-545.
82. Finley M.F., et al. BMP-4 inhibits neural differentiation of murine embryonic stem cells. J. Neurobiol. 1999, 40:271-287.
83. Ying Q.L., et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003, 115:281-292.
84. Shimozaki K., et al. Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures. Development 2003, 130:2505-2512.
85. Hammachi F., et al. Transcriptional activation by Oct4 is sufficient for the maintenance and induction of pluripotency. Cell Rep. 2012, 1:99-109.
86. Cirillo L.A., et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 2002, 9:279-289.
87. Yang V.S., et al. Geminin escapes degradation in G1 of mouse pluripotent cells and mediates the expression of Oct4, Sox2, and Nanog. Curr. Biol. 2011, 21:692-699.
88. Theunissen T.W., et al. Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr. Biol. 2011, 21:65-71.
89. Polo J.M., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
90. O'Malley J., et al. High-resolution analysis with novel cell-surface markers identifies routes to iPS cells. Nature 2013, 499:88-91.
91. Oka M., et al. Differential role for transcription factor Oct4 nucleocytoplasmic dynamics in somatic cell reprogramming and self-renewal of embryonic stem cells. J. Biol. Chem. 2013, 288:15085-15097.
92. Plachta N., et al. Oct4 kinetics predict cell lineage patterning in the early mammalian embryo. Nat. Cell Biol. 2011, 13:117-123.
93. Faunes F., et al. A membrane-associated beta-catenin/Oct4 complex correlates with ground-state pluripotency in mouse embryonic stem cells. Development 2013, 140:1171-1183.
94. Frum T., et al. Oct4 cell-autonomously promotes primitive endoderm development in the mouse blastocyst. Dev. Cell 2013, 25:610-622.
95. Aksoy I., et al. Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm. EMBO J. 2013, 32:938-953.
96. Zeineddine D., et al. Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev. Cell 2006, 11:535-546.
97. Teo A.K., et al. Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev. 2011, 25:238-250.
98. Palmieri S.L., et al. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol. 1994, 166:259-267.
99. Guo G., et al. Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst. Dev. Cell 2010, 18:675-685.
100. Downs K.M. Systematic localization of Oct-3/4 to the gastrulating mouse conceptus suggests manifold roles in mammalian development. Dev. Dyn. 2008, 237:464-475.
101. Yeom Y.I., et al. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 1996, 122:881-894.
102. Deveale B., et al. Oct4 is required ~e7.5 for proliferation in the primitive streak. PLoS Genet. 2013, 9:e1003957.
103. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144:940-954.
104. Whyte W.A., et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
105. Whyte W.A., et al. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 2012, 482:221-225.
106. Pardo M., et al. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 2010, 6:382-395.
107. van den Berg D.L., et al. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 2010, 6:369-381.
108. Ding J., et al. Oct4 links multiple epigenetic pathways to the pluripotency network. Cell Res. 2012, 22:155-167.
109. Palmqvist L., et al. Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency. Stem Cells 2005, 23:663-680.
110. Glover C.H., et al. Meta-analysis of differentiating mouse embryonic stem cell gene expression kinetics reveals early change of a small gene set. PLoS Comput. Biol. 2006, 2:e158.
111. Kaji K., et al. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nat. Cell Biol. 2006, 8:285-292.
112. Wang J., et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet. 2009, 41:125-129.
113. Reynolds N., et al. NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment. Cell Stem Cell 2012, 10:583-594.
114. Szabo E., et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468:521-526.
115. Efe J.A., et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 2011, 13:215-222.
116. Kim J., et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7838-7843.
117. Thier M., et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 2012, 10:473-479.
118. Hou P., et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341:651-654.